Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
5 Stocks That Look Promising Following Broker Rating Upgrades
08:31am, Monday, 11'th Nov 2024
Investors should monitor stocks like American Airlines, Air Canada, DXC, Dollar General, and McKesson for high returns.
McKesson: Q2 FY2025 Earnings, Growing U.S. Oncology Network
01:50am, Saturday, 09'th Nov 2024
I reiterate a 'Strong Buy' on McKesson, driven by growth from GLP-1 medications and a robust oncology network business, with a fair value of $696 per share. McKesson's acquisition of a 70% interest in
MCK Stock Gains as Q2 Earnings & Sales Top Estimates, '25 EPS View Up
12:15pm, Thursday, 07'th Nov 2024
McKesson's second-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.
These Analysts Boost Their Forecasts On McKesson Following Upbeat Earnings
09:07am, Thursday, 07'th Nov 2024
McKesson MCK reported better-than-expected second-quarter financial results on Wednesday.
McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript
07:59pm, Wednesday, 06'th Nov 2024
McKesson Corporation (MCK) Q2 2025 Earnings Call Transcript
McKesson (MCK) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
07:00pm, Wednesday, 06'th Nov 2024
Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Str
McKesson (MCK) Q2 Earnings and Revenues Beat Estimates
06:26pm, Wednesday, 06'th Nov 2024
McKesson (MCK) came out with quarterly earnings of $7.07 per share, beating the Zacks Consensus Estimate of $6.89 per share. This compares to earnings of $6.23 per share a year ago.
McKesson raises annual profit forecast on strength in its U.S. pharma segment
05:30pm, Wednesday, 06'th Nov 2024
Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S. pharmaceuticals segment on robust demand for specialty and branded drugs.
McKesson Corporation Reports Fiscal 2025 Second Quarter Results and Raises Full Year Adjusted EPS Guidance
04:10pm, Wednesday, 06'th Nov 2024
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2025 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve
Should You Buy, Sell or Hold McKesson Before Q2 Earnings?
02:51pm, Monday, 04'th Nov 2024
MCK's second-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.
Ahead of McKesson (MCK) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
10:20am, Friday, 01'st Nov 2024
Beyond analysts' top -and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter
McKesson Corporation Declares Quarterly Dividend
08:00am, Thursday, 31'st Oct 2024
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 71 cents per share of common stock. The dividend will be payable on J
McKesson (MCK) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 30'th Oct 2024
McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
McKesson (MCK) Beats Stock Market Upswing: What Investors Need to Know
07:06pm, Monday, 28'th Oct 2024
In the latest trading session, McKesson (MCK) closed at $508.95, marking a +0.3% move from the previous day.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
10:05am, Wednesday, 23'rd Oct 2024
McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
